Search research articles
Contact Us
Filters
Showing results (841-850 of 856) with videos related to
Page
of 86
Sort By:
Nature Biotechnology
|
July 26, 2020
Author Correction: Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populations
Jacob E Crawford, David W Clarke, Victor Criswell, et al.
The Lancet. Oncology
|
July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Silke Gillessen, Laura Murphy, Nicholas D James, et al.
Analytical and Bioanalytical Chemistry
|
June 29, 2021
Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2
Johanna E Camara, Stephen A Wise, Andrew N Hoofnagle, et al.
Analytical and Bioanalytical Chemistry
|
November 9, 2021
Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions
Christopher T Sempos, Emma L Williams, Graham D Carter, et al.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum
|
July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial
Nicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2024
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
C C Parker, P M Petersen, A D Cook, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
The European Respiratory Journal
|
October 13, 2022
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
Ekaterina Khaleva, Anna Rattu, Chris Brightling, et al.
Page
of 86
Search research articles
Search
Showing results (841-850 of 856) with videos related to
Sort By:
Page
of 86
Nature Biotechnology
|
July 26, 2020
Author Correction: Efficient production of male Wolbachia-infected Aedes aegypti mosquitoes enables large-scale suppression of wild populations
Jacob E Crawford, David W Clarke, Victor Criswell, et al.
The Lancet. Oncology
|
July 10, 2025
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Silke Gillessen, Laura Murphy, Nicholas D James, et al.
Analytical and Bioanalytical Chemistry
|
June 29, 2021
Assessment of serum total 25-hydroxyvitamin D assay commutability of Standard Reference Materials and College of American Pathologists Accuracy-Based Vitamin D (ABVD) Scheme and Vitamin D External Quality Assessment Scheme (DEQAS) materials: Vitamin D Standardization Program (VDSP) Commutability Study 2
Johanna E Camara, Stephen A Wise, Andrew N Hoofnagle, et al.
Analytical and Bioanalytical Chemistry
|
November 9, 2021
Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions
Christopher T Sempos, Emma L Williams, Graham D Carter, et al.
The Lancet. Oncology
|
May 4, 2023
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Gerhardt Attard, Laura Murphy, Noel W Clarke, et al.
JNCI Cancer Spectrum
|
July 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial
Nicholas D James, Fiona C Ingleby, Noel W Clarke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2012
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2024
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)
C C Parker, P M Petersen, A D Cook, et al.
International Journal of Cancer
|
April 12, 2022
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476)
Nicholas D James, Noel W Clarke, Adrian Cook, et al.
The European Respiratory Journal
|
October 13, 2022
Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA)
Ekaterina Khaleva, Anna Rattu, Chris Brightling, et al.
Page
of 86